Just another Daily Blogs News weblog
![]() The Malaysian Insider |
AstraZeneca, Rigel ink $1.25 bln drug pact
MarketWatch In return, the pharmaceutical major will get the rights to fostamatinib disodium, which passed a Phase II trial for rheumatoid arthritis, as well as similar … Rigel Down As AstraZeneca Deal Already Priced Into StockWall Street Journal Pharmaceutical Giants AstraZeneca (AZN), Rigel (RIGL) Collaborate On Arthritis …Benzinga Rigel Investors Balk at AstraZeneca DealMinyanville.com ABH News -Manchester Evening News -domain-B all 110 news articles » |
AstraZeneca, Rigel ink $1.25 bln drug pact – MarketWatch

Related posts:

Get News Headline on the motion